Richard Alan Lewis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Richard Alan Lewis has a total of 300 co-authors. Here are the top co-authors by number of shared publications:
- Jill A. Rosenfeld
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
5 shared publications - James R. Lupski
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA
4 shared publications Undiagnosed Diseases Network
3 shared publications- Brendan Lee
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
2 shared publications Donna M. Muzny
The Human Genome Sequencing Center and
2 shared publicationsJames R. Lupski
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States of America
2 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (9) , 102648
Uncovering Phenotypic Expansion in AXIN2-Related Disorders through Precision Animal Modeling
- 9 July 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (9) , 102648
Open AccessUncovering Phenotypic Expansion in AXIN2-Related Disorders through Precision Animal Modeling
- Open Access
- 17 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (42) , eadw3717
CEP76 impairment at the centrosome-cilium interface contributes to a spectrum of ciliopathies
Dysfunction at the centrosome-cilium interface underlies a broad range of ciliopathies. Here, we identify biallelic variants in CEP76 , encoding a centrosomal protein, in eight unrelated individuals presenting with neurodevelopmental, ocular, and variable additional multisystem features. Proband-derived fibroblasts and CEP76-depleted RPE1 cells display ciliary deficits, including impaired cilium formation and length, disrupted transition zone architecture, and impaired IFT88-mediated anterograde intraflagellar transport. Zebrafish cep76 mutants recapitulate key clinical phenotypes, and in vitro complementation assays confirm pathogenicity for all tested human disease-associated variants. Proteomics analysis identifies CEP76 interactors, including known partners CCP110 and CEP97, and highlights clinically and functionally relevant candidates, including ALMS1 and LUZP1. Together, these findings expand the role of CEP76 beyond centriole duplication to include ciliary assembly and trafficking, establishing it as a ciliopathy gene. This work provides mechanistic insights into CEP76 -related disease and broadens our understanding of centrosome-cilium biology.
- 17 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (42) , eadw3717
Open AccessCEP76 impairment at the centrosome-cilium interface contributes to a spectrum of ciliopathies
Dysfunction at the centrosome-cilium interface underlies a broad range of ciliopathies. Here, we identify biallelic variants in CEP76 , encoding a centrosomal protein, in eight unrelated individuals presenting with neurodevelopmental, ocular, and variable additional multisystem features. Proband-derived fibroblasts and CEP76-depleted RPE1 cells display ciliary deficits, including impaired cilium formation and length, disrupted transition zone architecture, and impaired IFT88-mediated anterograde intraflagellar transport. Zebrafish cep76 mutants recapitulate key clinical phenotypes, and in vitro complementation assays confirm pathogenicity for all tested human disease-associated variants. Proteomics analysis identifies CEP76 interactors, including known partners CCP110 and CEP97, and highlights clinically and functionally relevant candidates, including ALMS1 and LUZP1. Together, these findings expand the role of CEP76 beyond centriole duplication to include ciliary assembly and trafficking, establishing it as a ciliopathy gene. This work provides mechanistic insights into CEP76 -related disease and broadens our understanding of centrosome-cilium biology.
- Top Cited PapersOpen Access
- 11 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
FOXI3 pathogenic variants cause one form of craniofacial microsomia
Craniofacial microsomia (CFM; also known as Goldenhar syndrome), is a craniofacial developmental disorder of variable expressivity and severity with a recognizable set of abnormalities. These birth defects are associated with structures derived from the first and second pharyngeal arches, can occur unilaterally and include ear dysplasia, microtia, preauricular tags and pits, facial asymmetry and other malformations. The inheritance pattern is controversial, and the molecular etiology of this syndrome is largely unknown. A total of 670 patients belonging to unrelated pedigrees with European and Chinese ancestry with CFM, are investigated. We identify 18 likely pathogenic variants in 21 probands (3.1%) inFOXI3. Biochemical experiments on transcriptional activity and subcellular localization of the likely pathogenicFOXI3variants, and knock-in mouse studies strongly support the involvement ofFOXI3in CFM. Our findings indicate autosomal dominant inheritance with reduced penetrance, and/or autosomal recessive inheritance. The phenotypic expression of theFOXI3variants is variable. The penetrance of the likely pathogenic variants in the seemingly dominant form is reduced, since a considerable number of such variants in affected individuals were inherited from non-affected parents. Here we provide suggestive evidence that common variation in theFOXI3allele intranswith the pathogenic variant could modify the phenotypic severity and accounts for the incomplete penetrance.
- 11 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Top Cited PapersOpen AccessFOXI3 pathogenic variants cause one form of craniofacial microsomia
Craniofacial microsomia (CFM; also known as Goldenhar syndrome), is a craniofacial developmental disorder of variable expressivity and severity with a recognizable set of abnormalities. These birth defects are associated with structures derived from the first and second pharyngeal arches, can occur unilaterally and include ear dysplasia, microtia, preauricular tags and pits, facial asymmetry and other malformations. The inheritance pattern is controversial, and the molecular etiology of this syndrome is largely unknown. A total of 670 patients belonging to unrelated pedigrees with European and Chinese ancestry with CFM, are investigated. We identify 18 likely pathogenic variants in 21 probands (3.1%) inFOXI3. Biochemical experiments on transcriptional activity and subcellular localization of the likely pathogenicFOXI3variants, and knock-in mouse studies strongly support the involvement ofFOXI3in CFM. Our findings indicate autosomal dominant inheritance with reduced penetrance, and/or autosomal recessive inheritance. The phenotypic expression of theFOXI3variants is variable. The penetrance of the likely pathogenic variants in the seemingly dominant form is reduced, since a considerable number of such variants in affected individuals were inherited from non-affected parents. Here we provide suggestive evidence that common variation in theFOXI3allele intranswith the pathogenic variant could modify the phenotypic severity and accounts for the incomplete penetrance.
- 19 December 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (3) , 776-785
Expansion of the clinical and molecular spectrum of WWOX‐related epileptic encephalopathy
WWOX biallelic loss‐of‐function pathogenic single nucleotide variants (SNVs) and copy number variants (CNVs) including exonic deletions and duplications cause WWOX‐related epileptic encephalopathy (WOREE) syndrome. This disorder is characterized by refractory epilepsy, axial hypotonia, peripheral hypertonia, progressive microcephaly, and premature death. Here we report five patients with WWOX biallelic predicted null variants identified by exome sequencing (ES), genome sequencing (GS), and/or chromosomal microarray analysis (CMA). SNVs and intragenic deletions of one or more exons were commonly reported in WOREE syndrome patients which made the genetic diagnosis challenging and required a combination of different diagnostic technologies. These patients presented with severe, developmental and epileptic encephalopathy (DEE), and other cardinal features consistent with WOREE syndrome. This report expands the clinical phenotype associated with this condition, including failure to thrive in most patients and epilepsy that responded to a ketogenic diet in three patients. Dysmorphic features and abnormal prenatal findings were not commonly observed. Additionally, recurrent pancreatitis and sensorineural hearing loss each were observed in single patients. In summary, these phenotypic features broaden the clinical spectrum of WOREE syndrome.
- 19 December 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (3) , 776-785
Expansion of the clinical and molecular spectrum of WWOX‐related epileptic encephalopathy
WWOX biallelic loss‐of‐function pathogenic single nucleotide variants (SNVs) and copy number variants (CNVs) including exonic deletions and duplications cause WWOX‐related epileptic encephalopathy (WOREE) syndrome. This disorder is characterized by refractory epilepsy, axial hypotonia, peripheral hypertonia, progressive microcephaly, and premature death. Here we report five patients with WWOX biallelic predicted null variants identified by exome sequencing (ES), genome sequencing (GS), and/or chromosomal microarray analysis (CMA). SNVs and intragenic deletions of one or more exons were commonly reported in WOREE syndrome patients which made the genetic diagnosis challenging and required a combination of different diagnostic technologies. These patients presented with severe, developmental and epileptic encephalopathy (DEE), and other cardinal features consistent with WOREE syndrome. This report expands the clinical phenotype associated with this condition, including failure to thrive in most patients and epilepsy that responded to a ketogenic diet in three patients. Dysmorphic features and abnormal prenatal findings were not commonly observed. Additionally, recurrent pancreatitis and sensorineural hearing loss each were observed in single patients. In summary, these phenotypic features broaden the clinical spectrum of WOREE syndrome.
- 26 October 2022
- Published by Taylor & Francis
- p. 275-298
Calculating Statistical Tolerance Intervals Using SAS
Parametric tolerance intervals are frequently used for a variety of purposes in pharmaceutical development and manufacturing. Frequentist tolerance intervals are easily constructed for simple situations, such as when the data are independently and identically distributed, but difficulties may arise when encountering more complex situations, such as when it is necessary to incorporate information from multiple batches or different sources of variation. This chapter will use three step-by-step examples to show how SAS PROC MIXED, along with a DATA step and PROC UNIVARIATE, can be used to generate Bayesian tolerance intervals. The examples include a simple mean model, a one-way analysis of variance (ANOVA) model, and a one-way random-effects model.
- 26 October 2022
- Published by Taylor & Francis
- p. 275-298
Calculating Statistical Tolerance Intervals Using SAS
Parametric tolerance intervals are frequently used for a variety of purposes in pharmaceutical development and manufacturing. Frequentist tolerance intervals are easily constructed for simple situations, such as when the data are independently and identically distributed, but difficulties may arise when encountering more complex situations, such as when it is necessary to incorporate information from multiple batches or different sources of variation. This chapter will use three step-by-step examples to show how SAS PROC MIXED, along with a DATA step and PROC UNIVARIATE, can be used to generate Bayesian tolerance intervals. The examples include a simple mean model, a one-way analysis of variance (ANOVA) model, and a one-way random-effects model.
- 7 August 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (12) , 3516-3524
Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain
Cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder (CDD) is caused by heterozygous or hemizygous variants in CDKL5 and is characterized by refractory epilepsy, cognitive and motor impairments, and cerebral visual impairment. CDKL5 has multiple transcripts, of which the longest transcripts, NM_003159 and NM_001037343, have been used historically in clinical laboratory testing. However, the transcript NM_001323289 is the most highly expressed in brain and contains 170 nucleotides at the 3′ end of its last exon that are noncoding in other transcripts. Two truncating variants in this region have been reported in association with a CDD phenotype. To clarify the significance and range of phenotypes associated with late truncating variants in this region of the predominant transcript in the brain, we report detailed information on two individuals, updated clinical information on a third individual, and a summary of published and unpublished individuals reported in ClinVar. The two new individuals (one male and one female) each had a relatively mild clinical presentation including periods of pharmaco‐responsive epilepsy, independent walking and limited purposeful communication skills. A previously reported male continued to have a severe phenotype. Overall, variants in this region demonstrate a range of clinical severity consistent with reports in CDD but with the potential for milder presentation.
- 7 August 2022
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (12) , 3516-3524
Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain
Cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder (CDD) is caused by heterozygous or hemizygous variants in CDKL5 and is characterized by refractory epilepsy, cognitive and motor impairments, and cerebral visual impairment. CDKL5 has multiple transcripts, of which the longest transcripts, NM_003159 and NM_001037343, have been used historically in clinical laboratory testing. However, the transcript NM_001323289 is the most highly expressed in brain and contains 170 nucleotides at the 3′ end of its last exon that are noncoding in other transcripts. Two truncating variants in this region have been reported in association with a CDD phenotype. To clarify the significance and range of phenotypes associated with late truncating variants in this region of the predominant transcript in the brain, we report detailed information on two individuals, updated clinical information on a third individual, and a summary of published and unpublished individuals reported in ClinVar. The two new individuals (one male and one female) each had a relatively mild clinical presentation including periods of pharmaco‐responsive epilepsy, independent walking and limited purposeful communication skills. A previously reported male continued to have a severe phenotype. Overall, variants in this region demonstrate a range of clinical severity consistent with reports in CDD but with the potential for milder presentation.
- Open Access
GrASP: Gradient-Based Affordance Selection for Planning
Planning with a learned model is arguably a key component of intelligence. There are several challenges in realizing such a component in large-scale reinforcement learning (RL) problems. One such challenge is dealing effectively with continuous action spaces when using tree-search planning (e.g., it is not feasible to consider every action even at just the root node of the tree). In this paper we present a method for selecting affordances useful for planning -- for learning which small number of actions/options from a continuous space of actions/options to consider in the tree-expansion process during planning. We consider affordances that are goal-and-state-conditional mappings to actions/options as well as unconditional affordances that simply select actions/options available in all states. Our selection method is gradient based: we compute gradients through the planning procedure to update the parameters of the function that represents affordances. Our empirical work shows that it is feasible to learn to select both primitive-action and option affordances, and that simultaneously learning to select affordances and planning with a learned value-equivalent model can outperform model-free RL.
Open AccessGrASP: Gradient-Based Affordance Selection for Planning
Planning with a learned model is arguably a key component of intelligence. There are several challenges in realizing such a component in large-scale reinforcement learning (RL) problems. One such challenge is dealing effectively with continuous action spaces when using tree-search planning (e.g., it is not feasible to consider every action even at just the root node of the tree). In this paper we present a method for selecting affordances useful for planning -- for learning which small number of actions/options from a continuous space of actions/options to consider in the tree-expansion process during planning. We consider affordances that are goal-and-state-conditional mappings to actions/options as well as unconditional affordances that simply select actions/options available in all states. Our selection method is gradient based: we compute gradients through the planning procedure to update the parameters of the function that represents affordances. Our empirical work shows that it is feasible to learn to select both primitive-action and option affordances, and that simultaneously learning to select affordances and planning with a learned value-equivalent model can outperform model-free RL.
- 9 August 2018
- Published by American Society of Hematology in Blood
- Vol. 132 (6) , 658-662
Syndromic congenital myelofibrosis associated with a loss-of-function variant in RBSN
Publisher9s Note: There is a Blood Commentary on this article in this issue.
- 9 August 2018
- Published by American Society of Hematology in Blood
- Vol. 132 (6) , 658-662
Syndromic congenital myelofibrosis associated with a loss-of-function variant in RBSN
Publisher9s Note: There is a Blood Commentary on this article in this issue.
- Open Access
- 24 July 2017
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 13 (7) , e1006905
Clinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially
Dominant mutations in CACNA1A, encoding the α-1A subunit of the neuronal P/Q type voltage-dependent Ca2+ channel, can cause diverse neurological phenotypes. Rare cases of markedly severe early onset developmental delay and congenital ataxia can be due to de novo CACNA1A missense alleles, with variants affecting the S4 transmembrane segments of the channel, some of which are reported to be loss-of-function. Exome sequencing in five individuals with severe early onset ataxia identified one novel variant (p.R1673P), in a girl with global developmental delay and progressive cerebellar atrophy, and a recurrent, de novo p.R1664Q variant, in four individuals with global developmental delay, hypotonia, and ophthalmologic abnormalities. Given the severity of these phenotypes we explored their functional impact in Drosophila. We previously generated null and partial loss-of-function alleles of cac, the homolog of CACNA1A in Drosophila. Here, we created transgenic wild type and mutant genomic rescue constructs with the two noted conserved point mutations. The p.R1673P mutant failed to rescue cac lethality, displayed a gain-of-function phenotype in electroretinograms (ERG) recorded from mutant clones, and evolved a neurodegenerative phenotype in aging flies, based on ERGs and transmission electron microscopy. In contrast, the p.R1664Q variant exhibited loss of function and failed to develop a neurodegenerative phenotype. Hence, the novel R1673P allele produces neurodegenerative phenotypes in flies and human, likely due to a toxic gain of function. Calcium channels control the levels of calcium within cells and are important in human health. Indeed, groups of patients with disorders of balance known as ataxia have been found to have mutations in a calcium channel gene in the human genome called CACNA1A. CACNA1A mutations have also been observed in patients with particular forms of migraine leading to temporary paralysis on one side of the body (hemiplegia). Mutations in CACNA1A are increasingly found in even more severe brain phenotypes in childhood. This research focused on a group of 5 patients with that particularly severe CACNA1A-related disease. One of the patients had a particular genetic misspelling in CACNA1A while the other four had nearby misspellings. We used the fruitfly, Drosophila melanogaster, to generate flies with these same misspellings in a genetic background that lacked the fly version of the calcium channel. Interestingly, by studying these flies we saw differences between the mutation in Patient 1 and the other four patients. These differences suggest one of the mutations produces more neurodegeneration, and indeed we see more degeneration in that patient. The fly studies allowed us to understand the function of the mutations in these patients, and were helpful in guiding treatment decisions.
- 24 July 2017
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 13 (7) , e1006905
Open AccessClinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially
Dominant mutations in CACNA1A, encoding the α-1A subunit of the neuronal P/Q type voltage-dependent Ca2+ channel, can cause diverse neurological phenotypes. Rare cases of markedly severe early onset developmental delay and congenital ataxia can be due to de novo CACNA1A missense alleles, with variants affecting the S4 transmembrane segments of the channel, some of which are reported to be loss-of-function. Exome sequencing in five individuals with severe early onset ataxia identified one novel variant (p.R1673P), in a girl with global developmental delay and progressive cerebellar atrophy, and a recurrent, de novo p.R1664Q variant, in four individuals with global developmental delay, hypotonia, and ophthalmologic abnormalities. Given the severity of these phenotypes we explored their functional impact in Drosophila. We previously generated null and partial loss-of-function alleles of cac, the homolog of CACNA1A in Drosophila. Here, we created transgenic wild type and mutant genomic rescue constructs with the two noted conserved point mutations. The p.R1673P mutant failed to rescue cac lethality, displayed a gain-of-function phenotype in electroretinograms (ERG) recorded from mutant clones, and evolved a neurodegenerative phenotype in aging flies, based on ERGs and transmission electron microscopy. In contrast, the p.R1664Q variant exhibited loss of function and failed to develop a neurodegenerative phenotype. Hence, the novel R1673P allele produces neurodegenerative phenotypes in flies and human, likely due to a toxic gain of function. Calcium channels control the levels of calcium within cells and are important in human health. Indeed, groups of patients with disorders of balance known as ataxia have been found to have mutations in a calcium channel gene in the human genome called CACNA1A. CACNA1A mutations have also been observed in patients with particular forms of migraine leading to temporary paralysis on one side of the body (hemiplegia). Mutations in CACNA1A are increasingly found in even more severe brain phenotypes in childhood. This research focused on a group of 5 patients with that particularly severe CACNA1A-related disease. One of the patients had a particular genetic misspelling in CACNA1A while the other four had nearby misspellings. We used the fruitfly, Drosophila melanogaster, to generate flies with these same misspellings in a genetic background that lacked the fly version of the calcium channel. Interestingly, by studying these flies we saw differences between the mutation in Patient 1 and the other four patients. These differences suggest one of the mutations produces more neurodegeneration, and indeed we see more degeneration in that patient. The fly studies allowed us to understand the function of the mutations in these patients, and were helpful in guiding treatment decisions.
- Open Access
- 1 April 2017
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (4) , 412-420
Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene
- 1 April 2017
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (4) , 412-420
Open AccessWhole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene